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Cancer incidence continues to be a major health 
problem possibly because cancer is a complex 
system comprising many agents (1), so that various 
genetic factors such as fat-rich diets free from fruits 
and vegetables and the wrong life style can 
contribute to the development of various types of 
 Cancer is a multistage and multifactorial process in which genetic 
and environmental factors contribute to it. The results of the studies 
indicate the effective role of micronutrients, vitamins, and minerals 
in the treatment of malignancies. One of these elements, endorsed 
by the American Food and Drug Administration, is boron 
supplements. The present study reviews the role of boron 
supplementation in the prevention and treatment of cancer. At ISI, 
Pub Med, Science Direct, Google Scholar, Scopus, Iranmedex and 
Magiran  databases, we examined 41 studies conducted in the years 
1988-2018 regarding the effect of boron supplementation on cancer. 
The results showed that boron supplement is a useful and essential 
ingredient for humans with a daily intake of about 1-3 mg per day. 
Its rich diets have a significant reduction in the risk of developing a 
variety of cancers including prostate, breast, cervix and lung, liver, 
melanoma. The mechanisms by which boron may influence cancer 
is still unknown, but evidence suggests that boron has antioxidant 
and anti-inflammatory properties. Proposed mechanisms related to 
boron activity in cancer cells include inhibition of proteasezonin 
enzymatic activity, dehydrogenase, mRNA modification, and cell 
division and induction of apoptosis. Boron-containing compounds 
indicate promising effects for chemotherapy types of cancer. 
Its concluded that low levels of boron should be considered as a 
concern for health, and increasing the consumption of boron with its 
rich diets should be recognized as a rational and reasonable diet 
recommendation for the prevention and treatment of cancer, 
promotion of health and well-being. 
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cancer (2). Cancer is the third most common cause 
of death in Iran (3). Gastrointestinal cancers are the 
most frequent cancer among Iranian males and 
second to breast cancer among females (3, 4). 
Significant progress has been made in detection 
and early treatment of cancer recently which has 
improved its prediction. But long-term treatments 
for cancer, in addition to physical complications, 
affect the quality of life of these patients (5, 6). 
There is considerable evidence to support dietary 
recommendations for prevention of cancer as well 
as for patients undergoing or recovering from 
cancer treatment (7). The results of some studies 
indicate a positive effect of micronutrients, 
vitamins and minerals intake in the treatment of  
malignancies (8-10), so that nutritional 
supplements are widely used among patients with 
cancer who perceive them to be anticancer and 
antitoxicity agents (11), and often cancer survivors 
tend to start taking dietary supplements after 
receiving a diagnosis of cancer (12). The most 
commonly reported reasons for dietary supplement 
use were to improve health (e.g., immune system) 
and prevent disease (13), and manage the side 
effects of chemotherapy (14), also supplements 
could support the body to overcome the treatment-
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related- toxicities - and the relative oxidative stress 
in cancer patients (15). 
One of these proposed micronutrients is boron. 
The evidence indicates that boron is a useful and 
possibly essential element for humans (16, 17). 
Boron is a metalloid element with atomic number 
5(18), and in nature is not freely available in 
elemental form and is found as compounds. Boric 
acid (19) and calcium fructoborate are two boron-
containing compound that compared with other 
boron compounds have allocated most of the 
studies performed (20). People constantly intake 
boron from drinking water and food (21). The 
daily intake of boron is about 1-3 mg per day for 
most adults (18), and maximum level of boron 
intake recommended for all adults is 20 mg/day 
(22). The daily intake of boron depends on type of 
food stuffs, and the amount boron of water. Nuts 
and vegetables have higher concentration of boron 
than fruits and legume (18). About 85 percent of 
the consumed boron is absorbed (23). Since the 
regulation of plasma levels of boron is through the 
renal excretion, the effect of boron toxicity in 
animals and humans is rare (24, 25). Boron-rich 
diets significantly reduce the risk of developing a 
variety of cancers including prostate, breast, 
cervix, lung, liver, melanoma, bone marrow 
cancer, ovarian, pancreas and lymphoma (26). The 
mechanisms by which boron may influence cancer 
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is still unknown, but evidence suggests that boron  
acts through anti-oxidant and anti-inflammatory 
properties (9, 27, 28), inhibition of serine protease 
enzymatic activity, dehydration, mRNA processing, 
cell division and induction of apoptosis. Boron-
based compounds indicate promising effects for 
chemotherapy types of cancer (26).  
Considering the increasing prevalence of cancer in 
Iran and the non-invasive nature of complementary 
and boron medicine, we consider here implications 
from human, animal and in vitro studies of the 
effects of boron on cancer. 
Materials and Methods 
In order to investigate the related studies on the 
effects of boron on cancer, keywords  cancer and 
Boron supplementation  was searched  in the 
databases including  ISI, Pub Med,  Science Direct,  
Google Scholar, Scopus,  Iranmedex and Magiran 
from 1998 to 2017. Out of 148 articles by high 
search strategy, 41 studies were investigated in this 
study. Out of 41 articles obtained based on the 
keywords used, 28 interventional articles and 13 
descriptive articles are included in this study, which  
we deal  with some. 
Results 
Boron compounds in cancer prevention 
A diet with low boron has been found to lead to a 
number of general health problems and to increase 
cancer risk (26). Both animal and human data 
indicate that an intake of less than 1.0 mg/day 
inhibits the health benefits of boron. Dietary 
surveys indicate such an intake is not rare (29). 
The most common symptoms of boron deficiency 
include arthritis, memory loss, steoporosis, 
degenerative and soft cartilage diseases, hormonal 
disequilibria and a drop in libido (30).  
Boron and breast cancer prevention 
Today, breast cancer is the most common cancer 
type diagnosed in women (31). Breast cancer 
patients appear to have relative sex steroid 
hormone imbalance, in favour of estrogens (32). 
High bio-available testosterone counteracts the 
proliferative effects of estrogens on the mammary 
tissues and exerts a protective role to the breast, 
inhibiting cancer development and/or tumour 
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growth (33). Naghii et al. reported that after one 
week, supplementation of healthy males with 10 
mg boron/day resulted in a significant rise in the 
plasma free testosterone concentration (34). 
Calcitriol is a coordinate regulator of proliferation, 
differentiation and survival of breast cancer cell 
(35). Calcium Fructoborate increases the level of 
calcitriol in the blood, thus increases the level of 
protection against breast cancer (36). 
Boron and prostate cancer prevention 
A diet containing boric acid prevents the growth 
and transcription of prostate tumors (18), so that the 
increase in boron in the environment and diet is 
negatively correlated with hyperplasia and prostate 
cancer (26, 37). Prostate enlargement is an 
important risk factor for prostate cancer. 
Müezzinoğlu et al. in Turkey have measured the 
level of prostate specific antigen (PSA) and used 
sonography to measure men's prostate volume. 
These people lived in two villages with different 
levels of boron in water resources. Men living in a 
village with high boron had  significantly  smaller  
prostate glands  than men who lived in the village 
with low boron. However, there was no significant 
difference between the two groups in terms of PSA 
(37).  
Boron and cervical cancer prevention 
Korkmaz et al. reported that using high levels of 
boron in drinking water reduces the pathological 
risk of cervical cancer by conducting research in 
rich and deprived areas of boron in Turkey. The 
function of boron in preventing cervical cancer is 
not clear, but it seems that boron acts by inhibiting 
the HPV  receptors involved in cervical  cancer 
(38). 
Boron and lung cancer prevention 
In a study by Mahabir et al., they measured boron 
levels in women with lung cancer compared to 
healthy people over the past 10 years, and found 
that for women with lung cancer, low consumption 
of boron has a reverse relationship with the chance 
of lung cancer (39). 
Boron and liver cancer prevention 
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After induction of Hepatocellular carcinoma 
(HCC) in rats, Zafar and Ali observed that boron 
consumption (4 mg / kg body weight) orally for 
122 days significantly reduced proliferating cell 
nuclear antigen (PCNA) and ameliorated oxidative 
stress in mice exposed to cancer (40). 
Boron-mediated chemoprevention of cancer 
Cancer chemoprevention uses natural, synthetic or 
biological chemical agents to reverse, suppress or 
prevent carcinogenic progression (41).  Compounds 
of boron, which have an anticancer effect, include 
boric acid, borate, borate esters, boranes, borinic 
esters (26). Boric acid is one of the most studied 
boron-containing chemicals. Boric acid has been 
demonstrated to control the proliferation of some 
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Authors Year Type of study 
design 
Number of samples Findings   
Müezzinoğlu 
et al. 
2011 Prostate sonogra-
phy, 
measuring PSA 
level 
159 intervention groups: 159 people 
with high levels of boron(>1 mg /L) 
and 63 people with  low-boron 
sources(<1mg/L) 
Control group: 234 men without bo-
ron 
There was a significant dif-
ference in prostate size be-
tween the two groups 
There was no significant 
difference between the inter-
vention and control groups at 
PSA level 
  
Korkmaz et 
al. 
2007 Pap smear Intervention group: 472 women in 
the boron-rich region 
Control group: 87 women in the de-
prived area 
Significant differences in 
cytological changes in cervix 
between the two groups   
Mahabir et 
al. 
2008 Measuring the 
level of boron 
Intervention group: 763 women with 
lung cancer 
Control group: 38 healthy women 
There was a significant dif-
ference between the two 
groups for boron consump-
tion 
  
Zafar and Ali 2013 Measuring the 
level of PCNA 
Intervention group: 68 mice  suffered 
from HCC receiving 221 days of 
boron 
Control group: 80 mice suffered from  
HCC receiving 122 days of placebo 
Boron reduced PCNA and 
ameliorated oxidative stress 
in rats exposed to cancer   
Table: Clinical practice studies on boron and cancer 
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cancer cell types (19). Calcium fructoborate is a natural 
product that is extracted from plants, but it can also be 
produced by chemical synthesis (26). Calcium 
fructoborate is efficient in the prevention and treatment of 
cancer (25). Bortezomib is a borate ester that slows the 
growth of breast cancer cells and induces apoptosis in 
bone marrow, prostate, lung, ovary, pancreas, lymphoma 
and head and neck squamous cell carcinoma (SCC) (30). 
Conclusion 
Most of the in vitro and animal studies confirm the positive effects of supplementary boron on the prevention 
and treatment of cancer. Studies show that diets with low boron are common. And increasing in the 
consumption of boron by diets rich in fruits, vegetables, crops and legumes should be recognized as a 
rational diet recommendation to prevent and treat cancer, promote health and well-being. Physicians should 
be encouraged to more routinely discuss supplements use with their cancer patients and increase of clinical 
research on boron and cancer prevention seems necessary. 
